Patients using type 2 diabetes drugs known as thiazolidinediones, such as Actos and Avandia, in combination with the first-line treatment metformin, may be at an increased risk for developing community-acquired pneumonia, according to a new study published in the British Journal of Clinical Pharmacology. The study pitted the drug combination against sulfonylurea with metformin. Sulfonylurea drugs include the brands Diabinese, Amaryl, and Glucotrol. For the study, researchers identified 1,803 cases of community-acquired pneumonia, or CAP, in a cohort of type 2 diabetes patients. Researchers found that patients taking thiazolidinediones with metformin were more likely to develop CAP. There was no significant ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.